diabethic retinopathy.
Conditions
Interventions
Intervention 1: In short time (20 milli second duration time) group, pre-laser pupillary dilation and anesthesia was achieved with combination of tropicamide 1% drop for 3 times with 5 minute interval
Prevention
Treatment - Drugs
In short time (20 milli second duration time) group, pre-laser pupillary dilation and anesthesia was achieved with combination of tropicamide 1% drop for 3 times with 5 minute interval 30 minute befor
In conventional (100 milli second duration time) group, pre-laser pupillary dilation and anesthesia was achieved with combination of tropicamide 1% drop for 3 times with 5 minute interval 30 minute be
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: inclusion criteria: diabetic retinopathy exclusions criteria:previous retinal photocoagulation; preretinal or vitreous hemorrhage; significant media opacity; iris neovascularization; previous inetra ocular or retinal surgery; glaucoma; clinically significant macular edema at the time of treatment; asymmetrical involvement; mild and moderate diabetic retinopathy
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laser efficacy. Timepoint: 6 months. Method of measurement: clinical examination and retinal angiogeraphy.;Pain intensity. Timepoint: during laser. Method of measurement: visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Central macular thickness. Timepoint: 4 months. Method of measurement: macular OCT.;Best corrected visual acuity. Timepoint: 6 month. Method of measurement: ETDRS chart. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Mirshahi MD
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences
Outcome results
None listed